Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma Pamela C. Heaton Review Article 23 December 2012 Pages: 727 - 742
Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension Michelle OrmeAnnabel Boler Review Article 23 December 2012 Pages: 743 - 750
A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials Darren J. ClaysonDiane J. WildStephen Joel Coons Review Article 23 December 2012 Pages: 751 - 765
Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease Virginia L. PriestEvan J. BeggPaul Hansen Original Research Article 23 December 2012 Pages: 767 - 781
A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction Mark LamotteLieven AnnemansYork Zoellner Original Research Article 23 December 2012 Pages: 783 - 795
Costs of Inflammatory Bowel Disease in Germany Renee StarkHans-Helmut KönigReiner Leidl Original Research Article 23 December 2012 Pages: 797 - 814
Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada Michele KohliCheryl AttardMichael Marentette Original Research Article 23 December 2012 Pages: 815 - 830
National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget Slobodan M. JankovicNebojsa Milivojevic Correspondence 23 December 2012 Pages: 831 - 832